Labs Should Inform Medicare Beneficiaries Of Diagnostic Test Changes
This article was originally published in The Gray Sheet
Clinical laboratories need to help educate physicians and Medicare beneficiaries about proposed payment and procedural changes for clinical diagnostic laboratory tests resulting from the Health Care Financing Administration's negotiated rulemaking committee, according to Robert Murray, JD/PhD, Lutheran General Hospital, Park Ridge, Illinois.
You may also be interested in...
Members of the Negotiated Rulemaking Committee on Clinical Diagnostic Laboratory Tests are recommending that the "date of service" for Medicare claims be "the date the tested specimen was collected," but they admit that further discussion of the issue is warranted.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.